Medlive Technology Co Ltd
HKEX:2192

Watchlist Manager
Medlive Technology Co Ltd Logo
Medlive Technology Co Ltd
HKEX:2192
Watchlist
Price: 9.76 HKD -1.71%
Market Cap: 7.2B HKD
Have any thoughts about
Medlive Technology Co Ltd?
Write Note

Medlive Technology Co Ltd
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Medlive Technology Co Ltd
Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Medlive Technology Co Ltd
HKEX:2192
Cash Equivalents
ÂĄ4.4B
CAGR 3-Years
209%
CAGR 5-Years
205%
CAGR 10-Years
N/A
Y
Yidu Tech Inc
HKEX:2158
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Guiyang Longmaster Information & Technology Co Ltd
SZSE:300288
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B-SOFT Co Ltd
SZSE:300451
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Heren Health Co Ltd
SZSE:300550
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Winning Health Technology Group Co Ltd
SZSE:300253
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Medlive Technology Co Ltd
Glance View

Market Cap
7.1B HKD
Industry
Health Care

Medlive Technology Co., Ltd. operates as an investment holding company. The company is headquartered in Beijing, Beijing. The company went IPO on 2021-07-15. The firm mainly operates three segments. Its Precision Marketing and Corporate Solutions segment provides precision marketing solutions and corporate solutions. Its precision marketing solutions include digital detailing, digital marketing consulting and digital content creation services. Its revenue of its corporate solutions is primarily software as a service (SaaS). The Medical Knowledge Solutions segment mainly provides professional medical information and medical software services. The Intelligent Patient Management Solutions segment mainly provides online patient consultation and prescription services and patient management services. The firm mainly conducts its business within domestic market.

Intrinsic Value
6.74 HKD
Overvaluation 31%
Intrinsic Value
Price

See Also

What is Medlive Technology Co Ltd's Cash Equivalents?
Cash Equivalents
4.4B CNY

Based on the financial report for Dec 31, 2023, Medlive Technology Co Ltd's Cash Equivalents amounts to 4.4B CNY.

What is Medlive Technology Co Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
205%

Over the last year, the Cash Equivalents growth was 4%. The average annual Cash Equivalents growth rates for Medlive Technology Co Ltd have been 209% over the past three years , 205% over the past five years .

Back to Top